LY2452473

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LY2452473, covering 2011-04-15 to 2019-06-14. Get the full timeline:

Most recent: Clinical Trial Update: A Bioavailability Study of LY2452473 and Tadalafil [Phase 1]